BioCentury
ARTICLE | Clinical News

Forteo teriparatide: Phase I data

November 1, 2010 7:00 AM UTC

A double-blind, U.S. Phase I trial in 40 patients with severe, chronic periodontitis who underwent periodontal surgery showed that once-daily subcutaneous injections of 20 µg teriparatide plus calcium...